Clinical Trial: Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized, Double-masked, and Controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of Intravitreal Administration of Aflibercept in Japanese Patients With Same as current

Current Secondary Outcome: Proportions of subjects who have improved Neovascularization of the iris (NVI) grade from baseline to Week 1 [ Time Frame: Baseline and Week 1 ]

A subject who shows the improvement by at least one grade is considered to be improved.


Original Secondary Outcome: Same as current

Information By: Bayer

Dates:
Date Received: March 18, 2015
Date Started: April 2015
Date Completion:
Last Updated: September 9, 2016
Last Verified: September 2016